Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test

Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
FacebookXWhatsAppEmail

Approval expands access to Castle's precision medicine test designed to guide systemic treatment decision making in patients with moderate-to-severe atopic dermatitis